53 results
8-K
EX-99.1
VBIVQ
VBI Vaccines Inc
15 May 24
VBI Vaccines Reports First Quarter 2024 Financial Results
4:18pm
, fatigue, and headache.
There is a pregnancy exposure registry that monitors pregnancy outcomes in women who received PreHevbrio during pregnancy. Women
8-K
EX-99.1
VBIVQ
VBI Vaccines Inc
16 Apr 24
VBI Vaccines Reports Full Year 2023 Financial Results
8:00am
exposure registry that monitors pregnancy outcomes in women who received PreHevbrio during pregnancy. Women who receive PreHevbrio during pregnancy
8-K
EX-99.1
VBIVQ
VBI Vaccines Inc
14 Nov 23
VBI Vaccines Reports Third Quarter 2023 Financial Results
4:07pm
that monitors pregnancy outcomes in women who received PreHevbrio during pregnancy. Women who receive PreHevbrio during pregnancy are encouraged to contact 1
8-K
EX-99.1
cvnmqwctlh 1l1v
6 Sep 23
Regulation FD Disclosure
9:12am
8-K
EX-99.1
eqxataz6
14 Aug 23
VBI Vaccines Reports Second Quarter 2023 Financial Results
8:00am
8-K
EX-99.1
jilzn
24 Jul 23
VBI Vaccines Announces Closing of Underwriters’ Partial Exercise of Option to Purchase Additional Common Shares
8:00am
8-K
EX-99.1
2htna
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-99.2
vzv7tt7
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-99.1
ehfy0bp5qg mza9t
5 Jul 23
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-99.1
ftzh7f7a2xatifxwjrqf
15 Jun 23
VBI Vaccines Announces PreHevbri® is Now Available in the United Kingdom for the Prevention of Hepatitis B in Adults
8:00am
8-K
EX-99.1
5a6egpa688qilpofr
7 Jun 23
VBI Vaccines Announces Poster Presentation at EASL 2023
8:00am
8-K
EX-99.1
g9w6znputyg9
15 May 23
VBI Vaccines Reports First Quarter 2023 Financial Results
8:00am
8-K
EX-99.1
5f7bqe5z
25 Apr 23
VBI Vaccines Appoints Vaughn Himes to Board of Directors
8:00am
8-K
EX-99.1
jhduz2qo2jgft0zj
4 Apr 23
VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split
8:00am
8-K
EX-99.1
35exx7w7p37uc 91zm
10 Nov 22
VBI Vaccines Reports Third Quarter 2022 Financial Results and Provides Corporate Update
8:00am
8-K
EX-99.1
8502yjj36jun
15 Sep 22
VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures
5:01pm
8-K
EX-99.1
yrfncimpxbaq6
8 Sep 22
Regulation FD Disclosure
6:10am